These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 1547828

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Induction of CTL in vivo by major histocompatibility complex class I-peptide complexes covalently associated on the cell surface.
    Anjuère F, Horvath C, Cerottini JC, Luescher IF.
    Eur J Immunol; 1995 Jun; 25(6):1535-40. PubMed ID: 7614979
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Diversity and dominance among TCR recognizing HLA-A2.1+ influenza matrix peptide in human MHC class I transgenic mice.
    Man S, Ridge JP, Engelhard VH.
    J Immunol; 1994 Nov 15; 153(10):4458-67. PubMed ID: 7963521
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. TCR reactivity in human nickel allergy indicates contacts with complementarity-determining region 3 but excludes superantigen-like recognition.
    Vollmer J, Weltzien HU, Moulon C.
    J Immunol; 1999 Sep 01; 163(5):2723-31. PubMed ID: 10453014
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Predominant utilization of V beta 8+ T cell receptor genes in the H-2Ld-restricted cytotoxic T cell response against the immediate-early protein pp89 of the murine cytomegalovirus.
    Rodewald HR, Koszinowski UH, Eichmann K, Melchers I.
    J Immunol; 1989 Dec 15; 143(12):4238-43. PubMed ID: 2556481
    [Abstract] [Full Text] [Related]

  • 33. Alterations in TCR-MHC contacts subsequent to cross-recognition of class I MHC and singly substituted peptide variants.
    Ono T, DiLorenzo TP, Wang F, Kalergis AM, Nathenson SG.
    J Immunol; 1998 Nov 15; 161(10):5454-63. PubMed ID: 9820521
    [Abstract] [Full Text] [Related]

  • 34. Vaccination with T cell receptor peptides primes anti-receptor cytotoxic T lymphocytes (CTL) and anergizes T cells specifically recognized by these CTL.
    Kuhröber A, Schirmbeck R, Reimann J.
    Eur J Immunol; 1994 May 15; 24(5):1172-80. PubMed ID: 7514132
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Hapten addition to an MHC class I-binding peptide causes substantial adjustments of the TCR structure of the responding CD8(+) T cells.
    Honda S, Zhang W, Kalergis AM, DiLorenzo TP, Wang F, Nathenson SG.
    J Immunol; 2001 Oct 15; 167(8):4276-85. PubMed ID: 11591750
    [Abstract] [Full Text] [Related]

  • 37. Human TCR-gamma/delta alloreactive response to HLA-DR molecules. Comparison with response of TCR-alpha/beta.
    Flament C, Benmerah A, Bonneville M, Triebel F, Mami-Chouaib F.
    J Immunol; 1994 Oct 01; 153(7):2890-904. PubMed ID: 8089476
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Conserved V(D)J junctional sequence of cross-reactive cytotoxic T cell receptor idiotype and the effect of a single amino acid substitution.
    Hirama T, Takeshita S, Matsubayashi Y, Iwashiro M, Masuda T, Kuribayashi K, Yoshida Y, Yamagishi H.
    Eur J Immunol; 1991 Feb 01; 21(2):483-8. PubMed ID: 1705514
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.